We value your privacy; please be assured that we are not collecting any personal information through…
Ready, set, analyze: Amazon Omics unveils new Ready2Run workflows
Amazon Web Services (AWS) recently announced a significant expansion of Amazon Omics at the annual AWS Life Sciences Executive Symposium in Boston. Amazon Omics, which the company introduced last year, helps life science organizations to store, query and analyze genomic, transcriptomic and other omics data.
Other similar tools include Qlucore Omics Explorer, Genospace, StrandOmics, Signals Translational and the publicly-funded academic-developed platform Galaxy.
Omics data encompass genomics, transcriptomics and other related fields, providing a comprehensive understanding of the genetic, transcriptional and functional elements of biological systems. Such data, instrumental for researchers studying biological systems, plays a vital role in modern drug discovery and development.
Amazon Omics introduces Ready2Run workflowsAWS aims to distinguish Amazon Omics in the marketplace through its comprehensive managed service approach and unique features such as …
Harnessing the untapped potential of legacy data in pharma R&D
Pharmaceutical companies own petabytes of imaging data, generated by in-house research, investigator-initiated studies or clinical trials. This data is valuable and can yield insights that can help researchers better understand disease mechanisms and inform therapeutic approaches. But in many cases, researchers cannot access this important data, as it remains in silos with CROs, investigator labs, or within a specific research group…